These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 12494405)

  • 61. Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
    Göçmen C; Kumcu EK; Büyüknacar HS; Onder S; Singirik E
    Pharmacology; 2005 Oct; 75(2):69-75. PubMed ID: 16020948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Possible role of sildenafil in inhibiting rat vas deferens contractions by influencing the purinergic system.
    Bilge SS; Kesim Y; Kurt M; Aksoz E; Celik S
    Int J Urol; 2005 Sep; 12(9):829-34. PubMed ID: 16201980
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nucleotide pyrophosphatase antagonizes contractions due to the twitch component of the sympathetic nerve response and to applied ATP in the guinea-pig vas deferens.
    Satchell D
    Adv Exp Med Biol; 1989; 253B():493-6. PubMed ID: 2558548
    [No Abstract]   [Full Text] [Related]  

  • 64. Influence of temperature on stimulus-secretion coupling in the sympathetic nerves and on neuromuscular transmission, in guinea-pig vas deferens.
    Stjärne L; Alberts P
    Acta Physiol Scand; 1985 Oct; 125(2):181-94. PubMed ID: 2866659
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study.
    Stjärne L; Lundberg JM; Astrand P
    Neuroscience; 1986 May; 18(1):151-66. PubMed ID: 3755512
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relative pre- and postjunctional roles of noradrenaline and adenosine 5'-triphosphate as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens.
    Stjärne L; Astrand P
    Neuroscience; 1985 Mar; 14(3):929-46. PubMed ID: 2859555
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective impairment of noradrenergic transmission in the bisected rat vas deferens following photochemically-induced cerebral ischaemia.
    Boselli C; Gioglio L; Preda S; Govoni S
    Int J Androl; 2007 Jun; 30(3):129-36. PubMed ID: 17132152
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Direct evidence for concomitant release of noradrenaline, adenosine 5'-triphosphate and neuropeptide Y from sympathetic nerve supplying the guinea-pig vas deferens.
    Kasakov L; Ellis J; Kirkpatrick K; Milner P; Burnstock G
    J Auton Nerv Syst; 1988 Feb; 22(1):75-82. PubMed ID: 3351195
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prostaglandin E2 selectively affects purinergic transmission in guinea pig vas deferens.
    Hata F; Kishi I; Saeki K; Takeuchi T; Yagasaki O
    Neuropharmacology; 1991 Oct; 30(10):1107-12. PubMed ID: 1661863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Different calcium sources mobilized by noradrenaline (NA) and adenosine 5'-triphosphate (ATP): a basis for co-transmission in the rat vas deferens.
    Feddersen M; Vesperinas G; Lewin J; Huidobro-Toro JP
    Eur J Pharmacol; 1988 Aug; 153(2-3):313-4. PubMed ID: 2846321
    [No Abstract]   [Full Text] [Related]  

  • 71. P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens.
    von Kügelgen I; Kurz K; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):125-32. PubMed ID: 7909584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autoinhibition, sympathetic cotransmission and biphasic contractile responses to trains of nerve stimulation in the rodent vas deferens.
    Ventura S
    Clin Exp Pharmacol Physiol; 1998 Dec; 25(12):965-73. PubMed ID: 9887992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potentiation of sympathetic neuromuscular transmission mediated by muscarinic receptors in guinea pig isolated vas deferens.
    Iram S; Hoyle CH
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):212-20. PubMed ID: 15900515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Superoxide anion stress attenuates the contractile response of the Guinea pig vas deferens to ATP and diadenosine tetraphosphate. Possible effect on calcium dysregulation.
    Al-Rawi MB; Aleisa AM; Khattab MM
    Pharmacology; 2008; 82(2):142-7. PubMed ID: 18667840
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regional differences in the contractile and intracellular Ca2+ responses of the guinea-pig vas deferens to neurotransmitters and excess K+.
    Kato K; Tsutsui I; Furuya K; Ozaki T; Yamagishi S
    Exp Physiol; 1995 Sep; 80(5):721-33. PubMed ID: 8546862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Norepinephrine and ATP are synergistic in the mouse vas deferens preparation.
    Witt PA; Kramer TH; Burks TF
    Eur J Pharmacol; 1991 Nov; 204(2):149-55. PubMed ID: 1666875
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regional differences in the adenosine A(2) receptor-mediated modulation of contractions in rat vas deferens.
    Diniz C; Leal S; Gonçalves J
    Eur J Pharmacol; 2003 Jan; 460(2-3):191-9. PubMed ID: 12559381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endothelin-1 (ET)-induced mobilization of intracellular Ca2+ stores from the smooth muscle facilitates sympathetic cotransmission by potentiation of adenosine 5'-triphosphate (ATP) motor activity: studies in the rat vas deferens.
    Donoso MV; Montes CG; Lewin J; Fournier A; Calixto JB; Huidobro-Toro JP
    Peptides; 1992; 13(4):831-40. PubMed ID: 1332001
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Purinergic modulation of field stimulation responses of rat and human vas deferens smooth muscle.
    Lynch M; Huddart H
    Gen Pharmacol; 1991; 22(5):869-72. PubMed ID: 1761193
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants.
    Güneş A; Ceylan A; Sarioglu Y; Stefek M; Bauer V; Karasu C;
    Fundam Clin Pharmacol; 2005 Feb; 19(1):73-9. PubMed ID: 15660962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.